Studies have demonstrated associations between FGF23, obesity, and kidney disease, with FGF23 positively correlated with total body fat percentage, visceral fat, and male-pattern adipose tissue while showing a negative correlation with lean body mass (Parente et al., 2023). Here, FGF23 is linked to obesity due to melanocortin 4 receptor deficiency.